Close Menu

In Genome Biology this week, a team of researchers in Germany compared target genes of TFIIB and NC2 transcription factors in human B cells and analyzed the associated core promoter architectures. TFIIB occupancy is positively correlated with gene expression, the researchers write, and the majority of promoters are GC-rich and lack defined core promoter elements. They also found that NC2 binds to a highly related target gene set. "TFIIB and NC2 are global players that occupy active genes," the team writes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has launched a new tool that estimates someone's risk of developing severe COVID-19 if infected, Bloomberg reports.

The Guardian reports that Pasteur Institute researchers are halting their development of a SARS-CoV-2 vaccine following disappointing initial results.

The Wall Street Journal reports that an increased number of younger patients have been hospitalized as the new SARS-CoV-2 strain spread across the UK.

In Cell this week: proteomic patterns among COVID-19 affected tissue samples, transcriptome atlas of developing intestines, and more.